26 May 2013
Keywords: troubled, bioglan, revises, results, says, preliminary-stage, takeover
Article | 20 November 2001
On the insistence of KPMG Audit, the troubled UK drugmaker Bioglan,specializing in dermatological products and generics, has issued revised ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.